PharmD Info

A forum for Indian Pharmacy Professionals

Treatment Guidelines - Hospital Institutional Guidelines, Standard Treatment Guidelines, WHO Guidelines, Disease Treatment Guidelines and etc
Forum rules: The material, content provided by this forum is for informational purpose only and is not intended for substitute to medical advice, diagnosis or treatment.General rules are applicable for this forum- Find Here
  • User avatar
#3050
Ministry of Health and Family Welfare (MoHFW), India releases Framework for National Patient Safety Implementation

Strengthening Pharmacovigilance and Drug Safety being one of the Key Priority area in the frame work. Also establishing robust surveillance systems for monitoring patient safety.

Key Priority: Medication Safety

Adverse drug reaction surveillance will be strengthened and implemented across all public and private health care facilities with close coordination between state health departments, pharmacovigilance agencies, professional associations drug manufacturers and national vertical programs.

Download Here:
https://mohfw.gov.in/sites/default/file ... 520web.pdf
Similar Topics
Topics Statistics Last post
0 Replies 
1248 Views
by Admin
0 Replies 
1050 Views
by Admin
0 Replies 
1795 Views
by krishnaundela
National Pharmacovigilance Week - 2021
by Admin    - In: Pharma Talk
0 Replies 
1246 Views
by Admin
0 Replies 
991 Views
by Admin

Global manufacturers of laboratory plastic consuma[…]

Refer pdf

Economic questions vise notes

Refer pdf and pharm d guru also

ICH GCP CDSCO

ICH GCP CDSCO guidelines

PharmD Info - Highlights